Crocs, Inc. (CROX) Faces Securities Class Action over HEYDUDE Pipeline – Hagens Berman
January 24, 2025 19:33 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Investors in Crocs, Inc. (NASDAQ: CROX) suffered yet another loss on Oct. 29, 2024 after the company prepared investors for disappointing Q4 and FY...
Block, Inc. (XYZ) Faces Securities Class Action, Regulators Levy Cash App Fines Following Investigations Going Back to Hindenburg Report– Hagens Berman
January 24, 2025 18:24 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Investors in Block, Inc. (NYSE: SQ) n/k/a (NYSE: XYZ) began to learn of potentially adverse information about the company and its Square and Cash App...
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
January 24, 2025 10:38 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report...
FTAI (FTAI) Faces Potential Delay in Filing Annual Report Amid Securities Class Action – Hagens Berman
January 24, 2025 10:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI), a prominent aviation leasing and financing company, is facing a potential delay in filing its annual report for...
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
January 24, 2025 10:32 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege...
Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report – Hagens Berman
January 24, 2025 10:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024,...
AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman
January 24, 2025 10:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a...
ASP Isotopes (ASPI) Continue to Slump Despite Response to Short Seller Report – Hagens Berman
January 24, 2025 10:27 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Shares of ASP Isotopes Inc. (NASDAQ: ASPI) have continue their downward spiral falling 16% over the past five days, despite the company having issued...
Symbotic (SYM) Restates Financials, Faces Scrutiny Amid Accounting Concerns – Hagens Berman
January 24, 2025 10:19 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024...
Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues – Hagens Berman
January 22, 2025 14:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024...